Keyphrases
National Cohort Study
90%
During Pregnancy
90%
8-oxo-7,8-dihydroguanosine
58%
Type 2 Diabetic Patients
51%
Antibody Fragment
45%
Calcium Channel Blockers
45%
Adverse Drug Events
45%
Colorectal Cancer Patients
45%
Diclofenac
45%
Psoriasis
45%
Polymorphism
45%
Clarithromycin
45%
Antibiotics
45%
Poor Compliance
45%
8-oxoguanine
45%
Mebendazole
45%
Risk of Miscarriage
45%
Spontaneous Reporting
45%
Antimicrobial Guidelines
45%
Tracheal Aspiration
45%
Registry Study
45%
Urinary Excretion
45%
Gastrointestinal Toxicity
45%
Glucagon-like
45%
Potential Treatments
45%
Penicillin
45%
5-fluorouracil (5-FU)
45%
Microalbuminuria
45%
Type 2 Diabetes Prevention
45%
Chemotherapy
45%
Trimethoprim
45%
Randomized Controlled Trial
45%
Metabolic Pathway
45%
Poison Control Centers
45%
Early Pregnancy
45%
Polycystic Ovary Syndrome
45%
Asthma Severity
45%
Childhood Pneumonia
45%
Fertility Outcomes
45%
Adverse Drug Reaction
45%
TNF Inhibitors
45%
Tumour Necrosis Factor Inhibitor (TNFi)
45%
Birth Outcomes
45%
Misoprostol
45%
Denmark
38%
Placebo
36%
Methylenetetrahydrofolate Reductase (MTHFR)
36%
DNA Oxidation
35%
Penicillin V
34%
Antibiotic Drugs
34%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Antibiotics
90%
Nucleic Acid
90%
Trimethoprim
90%
Deoxyguanosine
77%
Placebo
76%
Clarithromycin
45%
Mebendazole
45%
Penicillin V
45%
Psoriasis
45%
Folic Acid
45%
Chemotherapy
45%
Colorectal Carcinoma
45%
5,10 Methylenetetrahydrofolate Reductase (FADH2)
45%
Tumor Necrosis Factor Inhibitor
45%
Pyrvinium Embonate
45%
Irbesartan
45%
Microalbuminuria
45%
Antiinfective Agent
45%
Penicillin
45%
Fluorouracil
45%
Calcium Channel Blocker
45%
Poison Control Center
45%
Gastrointestinal Toxicity
45%
Dulaglutide
45%
Spontaneous Abortion
45%
Randomized Controlled Trial
45%
Non Insulin Dependent Diabetes Mellitus
45%
Infection
35%
Congenital Malformation
28%
Adverse Event
27%
Thymidylate Synthase
22%
Anthelmintic Agent
22%
Reactive Oxygen Metabolite
22%
Malonaldehyde
22%
Fatality
17%
Medicine and Dentistry
Cohort Analysis
54%
Diclofenac Plus Misoprostol
45%
Asthma
45%
Antiinfective Agent
45%
Psoriasis
45%
Antibiotics
45%
Mebendazole
45%
TNF Inhibitor
45%
Adverse Drug Reaction
45%
Polycystic Ovary Syndrome
45%
Birth Outcomes
45%
Infection
35%
Congenital Malformation
28%
Antihelmintic
22%
